The Revised ESE Clinical Practice Guideline for Treatment of Chronic Hypoparathyroidism in Adults is almost complete.
As a member of ESE, we would like to request your assistance to finalise the document. Please find the relevant confidential documents below.
The guideline has been drafted by a panel of international experts, led by Professor Jens Bollerslev. These guidelines have been developed as the management of hypoparathyroidism (HypoPT) has changed since the first ESE clinical guideline was published in 2015, as has the knowledge on patient burden of the disease, and the understanding of primary and secondary morbidities.
These guidelines present recommendations for the diagnosis, management, and monitoring of chronic Hypoparathyroidism in adults, to give health care providers practical clinical guidance.
We would like to invite you as an ESE member to review and comment on the draft guidelines.
To provide your feedback, please:
1. Click this link to fill out your feedback form. Note: you will need to login to your ESE account.
3. Submit your feedback no later than 25 August 2025
You may save a draft of your feedback and return to it later. You may also submit more than one form should you have more than 15 comments. Please contact the Membership team at info@ese-hormones.org if you have any difficulties.
As with our previous guidelines, we will be implementing a transparent review process. Therefore, every comment by reviewers (including the response of the guideline authors) will be presented in the Appendix of the document. If you would prefer not to be mentioned by name, please indicate this in the form.
Finally, please note that until the time of publication, the documents below are confidential and should not be shared.